Dec 8 (Reuters) - BioNTech SE:
* PFIZER AND BIONTECH RECEIVE U.S. FDA EMERGENCY USE AUTHORIZATION FOR OMICRON BA.4/BA.5-ADAPTED BIVALENT COVID-19 VACCINE IN CHILDREN UNDER 5 YEARS Source text for Eikon: Further company coverage:
Dec 8 (Reuters) - BioNTech SE:
* PFIZER AND BIONTECH RECEIVE U.S. FDA EMERGENCY USE AUTHORIZATION FOR OMICRON BA.4/BA.5-ADAPTED BIVALENT COVID-19 VACCINE IN CHILDREN UNDER 5 YEARS Source text for Eikon: Further company coverage: